-
公开(公告)号：US20120184553A1
公开(公告)日：2012-07-19
申请号：US13498975
申请日：2010-09-27
申请人： Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
发明人： Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
IPC分类号： A61K31/5377 , A61K31/4406 , C07C235/56 , A61K31/167 , C07D237/20 , A61K31/50 , A61K31/4402 , C07D239/42 , A61K31/505 , C07D401/12 , A61K31/4545 , A61K31/496 , C07D413/12 , A61P25/16 , C07D213/75
CPC分类号： C07C235/64 , C07D213/75 , C07D231/40 , C07D237/20 , C07D261/14 , C07D263/48 , C07D401/12 , C07D403/12 , C07D413/12
摘要： The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
摘要翻译： 本发明涉及抑制LRRK2激酶活性的新化合物，其制备方法，含有它们的组合物及其用于治疗特征为LRRK2激酶活性，特别是帕金森病和阿尔茨海默病的疾病的用途。
-
公开(公告)号：US08778939B2
公开(公告)日：2014-07-15
申请号：US13498975
申请日：2010-09-27
申请人： Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
发明人： Paula Louise Nichols , Andrew John Eatherton , Paul Bamborough , Karamjit Singh Jandu , Oliver James Philps , Daniele Andreotti
IPC分类号： A61K31/5377 , A61K31/4406 , C07C235/56 , A61K31/167 , C07D237/20 , A61K31/50 , A61K31/4402 , C07D239/42 , A61K31/505
CPC分类号： C07C235/64 , C07D213/75 , C07D231/40 , C07D237/20 , C07D261/14 , C07D263/48 , C07D401/12 , C07D403/12 , C07D413/12
摘要： The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
摘要翻译： 本发明涉及抑制LRRK2激酶活性的新化合物，其制备方法，含有它们的组合物及其用于治疗特征为LRRK2激酶活性，特别是帕金森病和阿尔茨海默病的疾病的用途。
-
公开(公告)号：US20130225584A1
公开(公告)日：2013-08-29
申请号：US13820184
申请日：2011-08-31
申请人： Daniele Andreotti , Xuedong Dai , Andrew John Eatherton , Karamjit Singh Jandu , Qian Liu , Oliver James Philps
发明人： Daniele Andreotti , Xuedong Dai , Andrew John Eatherton , Karamjit Singh Jandu , Qian Liu , Oliver James Philps
IPC分类号： C07D403/12 , C07D213/75 , C07D237/20
CPC分类号： C07D403/12 , C07D213/75 , C07D231/12 , C07D237/20 , C07D261/14 , C07D295/192 , C07D401/12 , C07D413/12
摘要： The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by LRRK2 kinase activity, for example Parkinson's disease or Alzheimer's disease.
摘要翻译： 本发明涉及抑制LRRK2激酶活性的新化合物，其制备方法，含有它们的组合物及其用于治疗以LRRK2激酶活性为特征的疾病，例如帕金森病或阿尔茨海默氏病。
-
公开(公告)号：US09365551B2
公开(公告)日：2016-06-14
申请号：US13820184
申请日：2011-08-31
申请人： Daniele Andreotti , Xuedong Dai , Andrew John Eatherton , Karamjit Singh Jandu , Qian Liu , Oliver James Philps
发明人： Daniele Andreotti , Xuedong Dai , Andrew John Eatherton , Karamjit Singh Jandu , Qian Liu , Oliver James Philps
IPC分类号： C07D403/12 , C07D213/75 , C07D231/12 , C07D237/20 , C07D261/14 , C07D295/192 , C07D401/12 , C07D413/12
CPC分类号： C07D403/12 , C07D213/75 , C07D231/12 , C07D237/20 , C07D261/14 , C07D295/192 , C07D401/12 , C07D413/12
摘要： The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease or Alzheimer's disease.
摘要翻译： 本发明涉及抑制LRRK2激酶活性的新化合物，其制备方法，含有它们的组合物及其用于治疗以LRRK2激酶活性为特征的疾病，例如帕金森病或阿尔茨海默氏病。
-
5.发明申请公开(公告)号：US20080167351A1
公开(公告)日：2008-07-10
申请号：US11816284
申请日：2006-02-13
申请人： Daniele Andreotti , Luca Arista , Francesca Cardullo , Simone Spada , Kevin Michael Thewlis , Simon Edward Ward
发明人： Daniele Andreotti , Luca Arista , Francesca Cardullo , Simone Spada , Kevin Michael Thewlis , Simon Edward Ward
IPC分类号： A61K31/44 , C07D213/02 , C07C311/01 , A61K31/18 , C07D333/02 , A61K31/381 , A61P25/18
CPC分类号： C07D277/64 , C07D213/42 , C07D213/61 , C07D213/65 , C07D317/58 , C07D333/20
摘要： This invention relates to potentiation of the glutamate receptor by novel compounds of formula (I): The invention also relates to the use of the derivatives in treating diseases and conditions mediated by potentiation of the glutamate receptor, compositions containing the derivatives and processes for their preparation.
摘要翻译： 本发明涉及通过新的式（I）化合物增强谷氨酸受体：本发明还涉及该衍生物在治疗由谷氨酸受体增强介导的疾病和病症中的用途，含有衍生物的组合物及其制备方法 。
-
公开(公告)号：US5138048A
公开(公告)日：1992-08-11
申请号：US578949
申请日：1990-09-07
申请人： Bruno Tamburini , Alcide Perboni , Tino Rossi , Daniele Donati , Daniele Andreotti , Giovanni Gaviraghi , Stefano Biondi , Claudio Bismara
发明人： Bruno Tamburini , Alcide Perboni , Tino Rossi , Daniele Donati , Daniele Andreotti , Giovanni Gaviraghi , Stefano Biondi , Claudio Bismara
IPC分类号： C07D487/04 , A61K31/395 , A61K31/397 , A61K31/40 , A61K31/407 , A61P31/04 , C07C45/71 , C07C49/753 , C07D205/08 , C07D477/00 , C07D487/00 , C07F7/18
CPC分类号： C07D477/00 , C07C45/71 , C07C49/753 , C07D205/08 , C07F7/186 , Y02P20/55
摘要： Compounds of the general formula (I) ##STR1## in which: R.sub.1 represents a hydroxyl protecting group; andR.sub.2 represents a hydrogen or halogen atom, an azido group, a C.sub.1-3 alkyl group, a group (CH.sub.2).sub.m OR.sub.3 wherein m is zero or one and R.sub.3 represents a hydrogen atom or a hydroxyl protecting group, an azidoethoxy group, a protected hydroxyethoxy group or a group XR.sub.4 in which X is an oxygen atom or the group S(O).sub.n in which n is zero, 1 or 2 and R.sub.4 represents a C.sub.1-5 alkyl, C.sub.3-7 cycloalkyl or phenyl group or when X is oxygen or sulphur then R.sub.4 may also represent the group AlkNR.sub.5 R.sub.6 in which Alk represents a C.sub.2-6 straight or branched alkylene chain and R.sub.5 and R.sub.6 independently represent a hydrogen atom or C.sub.1-4 alkyl group or R.sub.5 and R.sub.6 together with the nitrogen atom to which they are attached form a pyrrolidino or piperidino ring or the group NR.sub.5 R.sub.6 represents a protected amino group, or R.sub.2 represents the group (CH.sub.2).sub.m NR.sub.7 R.sub.8 in which m is zero or 1 and R.sub.7 and R.sub.8 independently represent a hydrogen atom or a C.sub.1-4 alkyl group or NR.sub.7 R.sub.8 represents a protected amino group, or R.sub.2 and the carbon atom to which it is attached represent a keto group or a ketal derivative thereof; and acid addition salts of such compounds containing basic centers.
-
公开(公告)号：US20090023757A1
公开(公告)日：2009-01-22
申请号：US11910990
申请日：2006-04-06
申请人： Daniele Andreotti , Sergio Bacchi , Monica Delpogetto , Simone Guelfi , Alcide Perboni , Arianna Ribecai , Simone Spada , Paolo Stabile , Marsia Tampieri
发明人： Daniele Andreotti , Sergio Bacchi , Monica Delpogetto , Simone Guelfi , Alcide Perboni , Arianna Ribecai , Simone Spada , Paolo Stabile , Marsia Tampieri
IPC分类号： A61K31/519 , C07D471/04 , A61P1/00 , C07D207/14
CPC分类号： C07D471/04 , C07D207/22
摘要： The present invention relates to a novel process for preparing compounds of formula (IA), which are potent and specific antagonists of corticotropin-releasing factor (CRF) receptors, from intermediate compounds of formula (I), by a coupling reaction catalysed by copper.
摘要翻译： 本发明涉及通过由铜催化的偶联反应制备式（I）的中间体化合物来制备作为促肾上腺皮质激素释放因子（CRF）受体的有效和特异性拮抗剂的式（IA）化合物的新方法。
-
公开(公告)号：US06900183B2
公开(公告)日：2005-05-31
申请号：US10450886
申请日：2001-12-20
CPC分类号： C07H17/08 , A61K9/0019 , A61K9/2018
摘要： 11,12 γ lactone ketolides of the following formula: and pharmaceutically acceptable salts and solvates thereof, wherein R, R1, R2, and R3 are as described herein. The disclosure also relates to processes for the preparation of such compounds, to compositions containing them, and to their use in the therapy or prophylaxis of systemic or topical bacterial infections in a human or animal body.
摘要翻译： 具有下式的11,12个γ-内酯酮内酯及其药学上可接受的盐和溶剂合物，其中R 1，R 2，R 2和R 3， SUB>如本文所述。 本公开还涉及制备这些化合物的方法，含有它们的组合物及其在治疗或预防人或动物体内的全身或局部细菌感染中的用途。
-
公开(公告)号：US06531466B2
公开(公告)日：2003-03-11
申请号：US09781292
申请日：2001-02-13
申请人： Tino Rossi , Daniele Andreotti , Giovanna Tedesco , Luca Tarsi , Emiliangelo Ratti , Aldo Feriani , Domenica Antonia Pizzi , Giovanni Gaviraghi , Stefano Biondi , Gabriella Finizia
发明人： Tino Rossi , Daniele Andreotti , Giovanna Tedesco , Luca Tarsi , Emiliangelo Ratti , Aldo Feriani , Domenica Antonia Pizzi , Giovanni Gaviraghi , Stefano Biondi , Gabriella Finizia
IPC分类号： C07D47714
CPC分类号： C07D477/00
摘要： A compound of formula (I), salts and metabolically labile esters thereof, wherein R represents optionally substituted aryl or heteroaryl group; A represents a propylene chain or A is a chain of 3 members one of which is selected from an oxygen or sulphur atom or the group NH or a substituted derivative thereof and the other two members are methylene groups, having antibacterial activity, processes for their preparation and to their use in medicine.
摘要翻译： 式（I）的化合物，其盐和代谢不稳定的酯，其中R表示任选取代的芳基或杂芳基; A表示丙烯链或A是3个成员的链，其中一个选自氧或硫原子，或NH基或其取代衍生物，另外两个成员是具有抗菌活性的亚甲基，其制备方法 并用于医学。
-
公开(公告)号：US20210130306A1
公开(公告)日：2021-05-06
申请号：US16757096
申请日：2018-10-19
申请人： Laurence RAHME , Francois LEPINE , Damien MAURA , Carmela NAPOLITANO , Antonio FELICI , Michele NEGRI , Stefano FONTANA , Daniele ANDREOTTI , THE GENERAL HOSPITAL CORPORATION , APTUIT (VERONA) SRL, AN EVOTEC COMPANY
发明人： Laurence Rahme , Francois Lepine , Damien Maura , Carmela Napolitano , Antonio Felici , Michele Negri , Stefano Fontana , Daniele Andreotti
IPC分类号： C07D263/58 , C07C327/42 , C07D209/08 , C07C255/60 , C07C237/42
摘要： The present application provides malonamide compounds, and derivatives thereof (e.g., N-aryl malonamides (NAM), acetamides, oxalamides, and the like), that are useful, for example, for the treatment of acute, chronic/persistent, and/or relapsing infections. Pharmaceutical compositions, methods of treating diseases (e.g., bacterial infections), and methods of reducing bacterial virulence are also provided.
-
-
-
-
-
-
-
-
-
搜索结果
28 条记录 (耗时 0.035 秒)
